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On-Pump versus Off-pump Myocardial Revascularization in 
Patients with Renal Insufficiency: Early and Mid-term Results
Hwan  Wook  Kim,  M.D.*,  Jae-Won  Lee,  M.D.**,  Hyung  Gon  Je,  M.D.***, 
Soo  Hwan  Choi,  M.D.*,  Keon  Hyon  Jo,  M.D.*,  Hyun  Song,  M.D.*
Background:  Myocardial revascularization in patients with renal insufficiency is challenging to the cardiac surgeon, 
irrespective of utilizing extracorporeal circulation. This study aimed to compare the number of bypass grafts and the 
mid-term results and to evaluate independent survival predictors in patients with renal insufficiency undergoing 
on-pump or off-pump myocardial revascularization. Materials and Methods: We retrospectively analyzed the data of 
103 patients with renal insufficiency, who had isolated myocardial revascularization between January 1999 and 
January 2009. The patients were divided into two groups, the on-pump group and the off-pump group. Results: 
The off-pump group received a significantly greater number of distal arterial grafts than the on-pump group. 
However, the mean number of total grafts, the degree of complete revascularization, and survival rate of the pa-
tients were not significantly different between the two groups. Multivariate analysis showed the independent pre-
dictors for reduced mid-term survival were the number of total grafts and postoperative periodic renal replacement 
therapy. Off-pump myocardial revascularization does not decrease the number of bypass grafts or influence on the 
mid-term results for patients with renal insufficiency, compared to on-pump myocardial revascularization. Conclusion: 
Myocardial revascularization with a large number of total grafts has a beneficial effect on survival in patients with 
renal insufficiency, irrespective of utilizing extracorporeal bypass.
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INTRODUCTION
One of the issues of debate in myocardial revascularization 
has  been  that  whether  utilizing  extracorporeal  circulation  has 
an effect on the immediate & mid-term results of the patient. 
As  the  AHA  scientific  statement,  in  spite  of  merits;  namely, 
less  blood loss, less  need for transfusion, less  myocardial  en-
zyme  release  for  up  to  24  hours,  less  early  neurocognitive 
dysfunction  and  less  renal  insufficiency,  fewer  distal  grafts 
t e n d  t o  b e  a n a s t o m o s e d  w i t h  o ff-pump  myocardial  revascula-
rization than with standard on-pump myocardial revasculariza-
ti o n  [ 1 ] .  I n  a  r e t r o s p e c t i v e  s t u d y   by  the  Cleveland  Clinic,  al-
though  there  was  no  difference  in  the  mid-term  results,  sur-
vival,  freedom  from  myocardial  infarction,  and  freedom  from Hwan Wook Kim, et al
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percutaneous  coronary  reintervention,  the  on-pump  group  re-
ceived  a  great  number  of  bypass  grafts  than  the  off-pump 
group (3.5±1.1 versus 2.8±1.0, respectively, p＜0.001) [2]. In 
addition,  in  a  prospective  randomized  trial  by  Straka  et  al, 
fewer  distal  anastomoses  were  performed  in  the  off-pump 
group,  compared  to  the  on-pump  group  (2.7  versus  2.3,  re-
spectively,  p＜0.001)  [3].
By  the  way,  other  studies  have  addressed  the  question  of 
whether  patients  in  the  off-pump  group  receive  fewer  distal 
anastomoses  than  on-pump  group.  Puskas  et  al.  advocated 
off-pump  myocardial  revascularization  in  their  study  to  avoid 
transfusion requirements, or myocardial injury, and to achieve 
similar  complete  revascularization  [4].  Nevertheless,  other  au-
thors  are  more  hesitant,  considering  complete  revasculariza-
tion  with  the  off-pump  method  is  more  laborious  to  perform 
because  of the difficulty  of exposing the circumflex artery or 
its  branches  [5].
How about in patients with renal insufficiency? Renal dys-
function or malfunction can lead to fluid over-retention, plate-
let  dysfunction,  vascular  disease  and  susceptibility  to  in-
fections  that  the  cardiac  surgeon  would  want  to  avoid 
confronting. In particular, because coronary artery disease is a 
leading cause of death in patients with renal insufficiency [6], 
the  cardiac  surgeons  have  tried  to  overcome  this  combined 
problem  on  myocardial  revascularization.  Myocardial  re-
vascularization in patients with renal insufficiency is challeng-
ing  to  the  cardiac  surgeon,  irrespective  of  utilizing  ex-
tracorporeal  circulation,  and  off-pump  revascularization  is 
suggested  as  one  of  the  surgical  methods  to  avoid 
complications.  However,  several  studies  have  asked  the  ques-
tions  on  whether  off-pump  myocardial  revascularization 
would  be  of  advantage  to  the  long-term  survival  of  patients 
with  renal  insufficiency  [7-9].
The object of this study was to compare the number of by-
pass  grafts,  the  revascularized  territories  and  early-  and 
mid-term  results  of  patients  who  received  myocardial  re-
vascularization either utilizing extracorporeal circulation or the 
off-pump beating method, and to find the independent surviv-
al  predictors  for  patients  with  renal  insufficiency.       
MATERIALS AND METHODS
Between  January  1999  and  January  2009,  3,678  patients 
underwent  myocardial  revascularization.  Of  those  patients, 
138 patients were diagnosed with renal insufficiency, defined as 
estimated  glomerular  filtaration  rate  (GFR)＜30  mL/min/1.73 
m
2,  irrespective  of  the  need  for  periodic  renal  replacement 
therapy.  The  GFR  had  been  calculated  by  Modification  of 
Diet  in  Renal  Disease  study  equation.  28  patients  had  com-
bined  valvular  surgery,  and  follow-up  was  not  complete  in 
the other 7 patients. Consequently, 103 patients who had iso-
lated myocardial revascularization were included in the study. 
Patients  in  this  study  did  not  underwent  redo  myocardial  re-
vascularization at all. Sixty seven patients had myocardial re-
vascularization  utilizing  extracorporeal  circulation  (on-pump 
group)  and  off-pump  myocardial  revascularization  was  per-
formed for 36 patients (off-pump group). The selection of op-
erative  procedures  (namely,  on-pump  or  off-pump  myocardial 
revascularization)  was  based  on  the  followings:  Before  early 
2001,  we  have  performed  on-pump  myocardial  revasculariza-
tion  except  for  calcific  plaque  not  to  avoid  manipulating  on 
the  ascending  aorta.  However,  we  gradually  increased  the 
number  of  off-pump  myocardial  revascularization  from  early 
2001.  With  the  exception  of  a  stenotic  circumflex  coronary 
artery  located  deep  in  the  myocardium,  off-pump  myocardial 
revascularization  have  performed  for  all  coronary  arteries.
We  retrospectively  reviewed  the  clinical,  operative,  echo-
cardiographic  and  outcome  data  from  medical  or  surgical 
records.  Mid-term  follow-up  data  were  collected  from  tele-
phone  interviews  with  the  patient  and  family  members. 
Informed  consent  forms  were  obtained.
In-hospital  mortality  was  defined  as  death  within  30  days 
from  surgery.  Preoperative  cerebrovascular  accident  was  de-
fined  as  focal  neurologic  deficit  demonstrated  by  computed 
tomography  or  magnetic  resonance  imaging  before  operation. 
Preoperative myocardial infarction was defined as state or oc-
currence of regional hypokinesia or dyskinesia at preoperative 
echocardiography;  ST  segment  elevation  followed  by  appear-
ance of new Q wave at preoperative electrocardiogram; or in-
creased plasma concentration of creatinine kinase MB fraction 
greater  than  80  IU  [10].  Preoperative  periodic  renal  replace-
ment  therapy  (RRT)  was  defined  a s  th e  r e q u i r e m e n t  f o r  d ia l -Myocardial Revascularization in Renal Insufficiency
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Table 1. Preoperative data of the patients
Characteristic
Group  A 
(N=67)
on-pump 
Group  B 
(N=36)
off-pump
p-value
Age
Male
Serum  Cr  (mg/dL)
GFR  (mL/min/1.73  m
2)
  1 5 ∼59
  ＜15
RRT  history
  H D
  P D
Myocardial  function
  E F  ( % )
  L V E S D  ( m m )
    LVEDD  (mm)
PCI  history
MI  history
CVA  history
R i s k  f a c t o r  o f  
  coronary  disease
  D M
  H T N
    Hyperlipidemia
  S m o k i n g
62.5±7.4
54  (80.6%)
 5 . 4 ±2.6
23  (34.3%)
44  (65.7%)
29  (43.3%)
25  (37.3%)
4  (6.0%)
 4 8 . 7 ±13.2
39.2±8.7
54.8±7.0
2  (3.0%)
11  (16.4%)
6  (9.0%)
26  (38.8%)
24  (35.8%)
12  (17.9%)
20  (29.9%)
63.2±8.3
27  (75.0%)
5.9±5.1
12  (33.3%)
24  (66.7%)
16  (44.4%)
14  (38.9%)
2  (5.6%)
50.7±13.6
37.6±11.8
53.1±10.1
 7  ( 1 9 . 4 % )
 4  ( 1 1 . 1 % )
 7  ( 1 9 . 4 % )
21  (58.3%)
19  (52.8%)
18  (50.0%)
11  (30.5%)
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
0.008
NS
NS
0.058
0.096
＜0.001
NS
CVA=Cerebrovascular  accident;  DM=Diabetes  mellitus;  EF=Ejec-
tion  fraction;  GFR=Glomerula  filtration  rate;  HTN=Hyperten-
sion;  HD=Hemodialysis;  LVEDD=Left  ventricular  end  diastolic 
dimension;  LVESD=Left  ventricular  end  systolic  dimension; 
MI=Myocardial  infarction;  PCI=Percutaneous  coronary  interven-
tion;  PD=Peritoneal  dialysis;  RRT=Renal  replacement  therapy; 
NS=p＞0.1.
ysis  irrespective  of  mode  (specifically,  peritoneal  dialysis  or 
hemodialysis)  before  operation.  Postoperative  transient  RRT 
was  defined  as  the  requirement  for  dialysis  only  during  the 
in-hospitalization  period.  Newly  developed  periodic  RRT  was 
defined  as  new  requirement  for  dialysis  after  the  operation, 
c o n t i n u i n g  f o r  w h o l e  l i f e .  P o s t o p e r a t i v e  R R T  w a s  d e f i n e d  a s  
the  sum  of  the  number  of  preoperative  patients  on  periodic 
RRT  and  postoperative  patients  on  newly  developed  periodic 
RRT.  Completeness  revascularization  was  identified  by  com-
paring the number of graft performed with the number of dis-
eased  coronary  systems  (specifically,  more  than  50%  stenosis 
in the left anterior descending coronary artery, circumflex and 
right coronary artery systems) found on the preoperative coro-
nary  angiography  [4].
All  continuous  variables  were  expressed  as  mean±S.D  and 
were tested using a Student t test. Categorical data were test-
ed  using  Chi-square  statistics.  For  multivariate  analysis,  the 
Cox  proportional  hazards  model  was  fitted  with  time  to 
survival.  The  Kaplan  Meier  method  was  used  to  calculate 
survival  curves,  and  survival  of  subgroups  was  compared  by 
the  log  rank  test.  The  SPSS  software  package  14.0  (SPSS 
Inc,  Chicago,  IL)  was  used  for  statistical  analysis.  A  p  value 
of  0.05  or  less  was  considered  statistically  significant  in  all 
cases. 
RESULTS
The demographic and preoperative data are shown in Table 
1. Results showed that patients in both groups were similar in 
terms  of  age,  sex,  preoperative  serum  creatinine  level  (Cr) 
and  estimated  GFR.  Myocardial  function  and  history  of  renal 
replacement  therapy  were  not  different  between  the  two 
groups.  However,  a  preoperative  percutaneous  coronary  inter-
vention  (PCI)  history  and  the  presence  of  hyperlipidemia, 
which  is  one  of  the  risk  factors  for  coronary  disease,  were 
often  found  in  the  off-pump  group  (p＜0.01).  Other  risk  fac-
tors  of  atherosclerosis  did  not  significantly  differ  in  the  both 
groups.
Bypass  graft  information  is  shown  in  Table  2.  The  off- 
pump  group  received  a  significantly  greater  number  of  distal 
targets with arterial grafts than the on-pump group, p＜0.001. 
However,  distal  number  of  targets  with  venous  grafts  are 
even greater in the on-pump group (p＜0.001). Therefore, the 
mean  number  of  total  targets  with  grafts  was  3.5±1.2  and 
3.1±1.3  for  the  on-pump  and  the  off-pump  group,  re-
spectively (p＞0.1). In almost all patients of both groups, the 
left  internal  thoracic  artery  was  used  as  a  graft  vessel. 
Furthermore,  between  the  two  groups,  there  is  no  difference 
of statistical results according to the completeness revasculari-
zation and the revascularized territories, respectively (Table 2, 
3).
Table  4  shows  the  postoperative  data  of  the  both  groups. 
There was no difference in the ejection fraction (EF) between 
the  two  groups  during  the  follow-up  period.  However,  the 
length  of  stay  and  follow-up  periods were  significantly short-Hwan Wook Kim, et al
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Table 2. B ypass  graft data of the patients
Variable
Group  A 
(N=67)
on-pump
Group  B 
(N=36)
off-pump
p-value
N o .  o f  t o t a l  t a r g e t s  
  with  grafts
No.  of  distal  targets 
  with  arterial  grafts
No.  of  distal  targets 
  with  venous  grafts
LITA  usage
ICOR
3.5±1.2
1.5±1.0
2.0±1.3
62  (92.5%)
1.14±0.05
3.1±1.3
2.5±1.3
0.6±0.7
36  (100%)
1.03±0.07
0.064
＜0.001
＜0.001
NS
NS
ICOR=Index  of  completeness  of  revascularization  (number  of 
grafts  performed/number  of  grafts  intended);  LITA=Left  internal 
thoracic  artery;  NS=p＞0.1.
Table 3. Revascularized territories data of the patients
Variable
Group  A 
(N=67)
on-pump
Group  B 
(N=36)
off-pump
p-value
No.  of  LAD  territory
No.  of  LCx  territory
No.  of  RCA  territory
1.5±0.5
1.2±0.3
0.8±0.6
1.4±0.2
1.2±0.5
0.5±0.4
NS
NS
0.083
LAD=Left  anterior  descending  coronary  artery  and  branch  ves-
sels;  LCx=Left  circumflex  coronary  artery  and  branch  vessels; 
RCA=Right  coronary  artery  and  branch  vessels;  NS=p＞0.1.
Table 4. Postoperative data of the patients
Variable
Group  A 
(N=67)
on-pump
Group  B 
(N=36)
off-pump
p-value
Length  of  stay
Last  echocardiographic 
 E F  ( % )
Early  mortality
Postop  complication 
  (excluding  renal
 p r o b l e m )
Preop  periodic  RRT
Postop  periodic  RRT
Newly  developed
 p e r i o d i c  R R T  
Postop  temporally  RRT 
Follow-up  (month)
14.5±11.7
50.5±13.0
6  (9%)
10  (14.9%)
29  (43.3%)
50  (74.6%)
21  (31.3%)
9  (13.4%)
40.5±31.5
9.3±3.7
53.4±10.8
0  (0%)
2  (5.6%)
16  (44.4%)
22  (61.1%)
 6  ( 1 6 . 7 % )
2  (5.5%)
23.5±20.2
＜0.001
NS
0.064
NS
NS
NS
NS
NS
＜0.001
EF=Ejection  fraction;  RRT=Renal  replacement  therapy;  NS=p＞
0.1.
er in the off-pump group (p＜0.01). Complications other than 
renal  problems  developed  more  often  in  the  on-pump  group 
but  there  was  no  significant  difference  (p＞0.1).  The  main 
complications  in  the  on-pump  group  were  bleeding  (N=4), 
low  cardiac  output  syndrome  (N=3),  wound  infection  (N=3), 
CVA  (N=3),  pneumonia  (N=1),  sepsis  (N=1)  and  tamponade 
( N = 1 ) .  U s u a l l y  o n e  p a t i e n t  h a d  m o r e  t h a n  o n e  c o m p l i c a t i o n .  
In  the  off-pump  group,  however,  there  were  2  wound  in-
fections and 1 case of pneumonia occurring in 2 patients. The 
deteriorations  of  renal  function  developed  in  21  patients  in 
the  on-pump  group  and  6  patients  in  the  off-pump  group, 
who  did  not  need  RRT  preoperatively.  Postoperatively,  they 
needed periodic permanent hemodialysis but there was no sig-
nificant  difference  (p＞0.1).  At  discharge,  74.6%  of  patients 
(N=50)  in  the  on-pump  group  and  61.1%  of  patients  (N=22) 
in  the  off-pump  group  were  dependent  on  periodic  renal  re-
placement  therapy.  Death  of  6  patients  occurred  in  the 
on-pump  group  during  the  hospitalization  period,  resulting  in 
a  hospital  mortality  rate  of  5.8%  (6  of  103).  3  patients  died 
of  low  cardiac  output  syndrome  with  newly  developed  atrial 
fibrillation;  the  cause  of  death  for  the  remaining  3  patients 
was cerebrovascular accident, respiratory failure with pneumo-
nia and sepsis. The mean follow-up periods of the 97 hospital 
survivors  was  36.69  months  (range,  0.9  to  116.8  months). 
During  follow-up,  1  patient  in  the  on-pump  group  and  1  pa-
tient  in  the  off-pump  group  underwent  renal  transplantation 
and  are  still  surviving.  In  the  on-pump  group,  ten  of  the  23 
late  deaths  were  from  cardiac  causes,  2  patients  from  cere-
brovascular  disease,  and  the  other  patients  from  causes  un-
related  to  the  vascular  system.  Meanwhile,  three  of  the  five 
late  deaths  in  the  off-pump  group  were  from  the  car-
diovascular  disease  (Table  5). 
To  identify  factors  influencing  the  survival  rate,  several 
v a r i a b l e s  w e r e  a n a l y z e d  u s i n g  t h e  C o x  r e g r e s s i o n  m o d e l .  
Univariate  analysis  showed  that  only  the  number  of  total 
grafts  acted  as  a  determinant  of  the  postoperative  survival 
rate.  Postoperative  periodic  RRT  trended  toward  being  an  in-
dependent  factor  for  survival  (Table  6). 
However,  at  multivariate  analysis  using  the  Cox  propor-
tional  hazards  modeling  on  variables  after  exclusion  of  peri-
operative  deaths,  the  independent  predictors  for  reduced  sur-Myocardial Revascularization in Renal Insufficiency
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Table 5. The causes of deaths of the 97 hospital survivors
Causes
Group  A 
(N=61)
on-pump
Group  B 
(N=36)
off-pump
Cardiac 
    Congestive  heart  failure
    Sudden  sustained  arrythmia
    New  ischemic  insult  to  myocardium
Non-cardiac
    Cerebrovascular  hemorrahge
    Bowel  ischemia
  S e p s i s
    Cholecystitis  with  hepaticrenal
      encephalopathy
    Peritonitis
    Pneumonia
    GI  bleeding
    Hepatic  failure  related  with  HBV
  C a n c e r
Unknown
Total
5
2
3
2
1
1
1
1
1
2
2
1
1
23
1
1
1
1
1
5
GI=Gastrointestinal;  HBV=Hepatitis  B  virus.
Table 6. Univariate analysis of risk factors for survival
Variable Hazard  ratio  95%  CI  p-value
Preop  EF  (%)
Preop  LVESD  (mm)
N o .  o f  t o t a l  g r a f t s
No.  of  distal  arterial  grafts
No.  of  RCA  territory
Preop  periodic  RRT 
Postop  periodic  RRT 
0.98
1.01
0.70
0.93
0.89
1.37
3.34
0.92∼1.04
0.93∼1.09
0.48∼0.99
0.62∼1.40
0.90∼1.03
0.55∼3.41
 0 . 9 0 ∼12.31
NS
NS
0.046
NS
NS
NS
0.071
CI=Confidence  interval;  EF=Ejection  fraction;  LVESD=Left 
ventricular  end  systolic  dimension;  RCA=Right  coronary  artery 
and  branch  vessels;  RRT=Renal  replacement  therapy;  NS=p＞
0.1.
Table 7. Multivariate analysis of risk factor for survival with the 
Cox proportional hazards model
Variable Hazard  ratio  95%  CI  p-value
Preop  EF  (%)
Preop  LVESD  (mm)
N o .  o f  t o t a l  g r a f t s
No.  of  distal  arterial  grafts
No.  of  RCA  territory
Preop  periodic  RRT
Postop  periodic  RRT 
0.98
1.03
0.64
0.82
0.96
1.86
4.06
0.95∼1.01
0.99∼1.07
0.46∼0.90
0.59∼1.14
0.96∼1.01
0.87∼3.96
 1 . 2 2 ∼13.53
NS
NS
0.008
NS
NS
NS
0.022
CI=Confidence  interval;  EF=Ejection  fraction;  LVESD=Left 
ventricular  end  systolic  dimension;  RCA=Right  coronary  artery 
and  branch  vessels;  RRT=Renal  replacement  therapy;  NS=p＞
0.1.
Fig. 1. Kaplan-Meier survival curve of all patients.
vival  after  hospital  discharge  were  the  number  of  total  grafts 
and  postoperative  periodic  renal  replacement  therapy  (Table 
7). 
The  survival  rates  of  all  discharged  patients  at  1,  3  and  5 
years  were  92.6%,  85.0%  and  64.1%  respectively  (Fig.  1).
Survival rates of the on-pump group declined more rapidly 
than  those  of  the  off-pump  group  during  the  immediate  post-
operative  period  due  to  higher  in-hospital  mortality,  but  the 
on-pump  group  showed  a  similar  survival  rate  to  the 
off-pump  group  after  the  perioperative  period  (Fig.  2).  The 
survival rates of discharged patients at 1, 3 and 5 years were 
90.0%,  86.1%  and  62.7%  in  the  on-pump  group,  and  97.1%, 
79.0%  and  69.1%  in  the  off-pump  group,  respectively.  In 
s p i t e  o f  t h e  d i f f e r e n c e s  i n  m o r t ality  during  the  perioperative 
period,  there  was  no  significant  difference  in  the  5  year  sur-
vival  rate  between  the  both  groups  by  log  rank  statistic 
(p=0.57).  Freedom  from  cardiac  related  death  at  3  and  5 
years  were  95.7%  and  77.7%  in  the  on-pump  group,  and 
81.3% and 71.2% in the off-pump group (p＞0.1 by log rank 
statistic)  (Fig.  3). Hwan Wook Kim, et al
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Fig. 2. Kaplan-Meier survival curve of both groups.
Fig. 3. Freedom from cardiac related death of the 97 hospital 
survivors.
DISCUSSION
Whether  complete  myocardial  revascularization  or  the  use 
of  extracorporeal  circulation  is  more  beneficial  in  patients 
with  renal  insufficiency  is  a  question  of  great  importance  for 
the cardiac surgeon. Patients with renal dysfunction have sev-
eral  obstacles  that  prevent  optimal  revascularization  and  con-
tribute  to  an  unfavorable  postoperative  outcome.  Pressure 
overload as a result of stiffness of large capacity arteries like 
the aorta, and volume overload as a result of chronic fluid re-
tention  lead  to  left  ventricular  hypertrophy  and  increased  left 
ventricular  end  diastolic  diameter,  which  makes  patients  with 
renal  dysfunction  susceptible  to  ischemic  insult  and  left  ven-
tricular  dysfunction  [11,12].  Probably,  these  pathophysiologic 
changes  in  myocardium  render  off-pump  myocardial  re-
vascularization difficult. In addition, a significantly greater in-
cidence  of  plaques  has  been  reported  in  the  common  carotid 
artery,  rendering  patients  more  prone  to  perioperative  ische-
mic cerebral insult [9]. High level exposure to traditional risk 
factors  such  as  smoking  and  dyslipidemia,  and  also  endothe-
lial  dysfunction,  commonly  characterized  by  reduced  pro-
duction  of  the  vasodilator  nitric  oxide  (NO),  are  thought  to 
b e  a  f a c t o r s  l e a d i n g  t o  a  w o r se  postoperative  outcome 
[13,14].
An  overview  of  the  available  literature  summarizing  the 
perioperative  mortality  rate  for  isolated  myocardial  revascula-
rization  for  patients  with  renal  insufficiency  shows  a  rate  of 
8.9%,  with  increased  but  acceptable  perioperative  mortality. 
This  mortality  ratio  is  lower  than  that  of  isolated  cardiac 
valve surgery and a combined procedure (19.3 and 39.5% re-
spectively) [15]. Therefore, cardiac procedures, especially my-
ocardial  revascularization,  to  relieve  ischemic  insult  is  the 
best  treatment  for  patients  with  renal  insufficiency  having  is-
chemic  heart  disease.  In  particular,  when  comparing  my-
ocardial revascularization with PCI in patients receiving RRT, 
there may be better long-term  survival  and  freedom  from  an-
gina  with  myocardial  revascularization,  compared  with  bal-
loon  angioplasty  [16].
However,  the  inherent  side  effects  of  conventional  my-
ocardial  revascularization  utilizing  extracorporeal  circulation 
may impose more serious problems on patients with renal in-
sufficiency, especially such as bleeding tendency due to plate-
let  malfunction,  fluid  overloading,  systemic  inflammatory  re-
actions  and  compromise  of  renal  function.  A  prospective 
randomized study, by Ascione et al. shows that off-pump my-
ocardial  revascularization  offers  superior  renal  protection 
when  compared  with  the  on-pump,  namely  conventional  my-
ocardial  revascularization  in  first  time  coronary  revascularied 
patients.  Furthermore,  glomerular  filtration  was  assessed  by 
creatinine  clearance  and  the  urinary  microalbumin/creatinine 
ratio, which was significantly worse in the on-pump group. In 
addition, compared to the off-pump group, renal tubular func-
tion  was  also  impaired  in  the  on-pump  group  as  assessed  by 
an  increased  N-acetyl  glucosaminidase  activity  [17]. 
Also,  Osaka  et  al.  suggest  that  off-pump  myocardial  re-Myocardial Revascularization in Renal Insufficiency
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vascularization  has  several  advantages  compared  to  on-pump 
myocardial  revascularization  for  patients  with  renal  in-
sufficiency,  in  that  there  is  less  bleeding,  the  systemic  in-
flammatory response syndrome can be avoided and electrolyte 
imbalance can be prevented [18]. In the case of calcified and 
narrow  native  stenotic  coronary  arteries,  distal  anastomosis 
may  be  difficult  to  perform,  so  emphasis is placed upon pre-
cise  preoperative  angiographic  evaluation  of  native  coronary 
arteries.  However,  the  authors  concluded  that  graft  anasto-
mosis  problems  in  difficult  cases  may  be  improved  dramati-
cally  as  experience  with  off-pump  revascularization  increases. 
Moreover,  it  is  well  known  that  off-pump  myocardial  re-
vascularization  reduces  postoperative  complications  and  early 
mortality  in  patients  with  renal  insufficiency  [19-21].  In  our 
study,  although  there  is  no  difference  in  the  complications 
other than a renal problem in the both groups (p＞0.1), early 
m o r t a l i t y  s h o w e d  a  t r e n d  o f  b e i n g  l o w e r  i n  t h e  o f f - p u m p  
group,  p＜0.064.  Furthermore,  Yokoyama  et  al.  concluded 
that  off-pump  myocardial  revascularization  had  a  consistent 
trend  of  reducing  morbidity  and  early  mortality  overall,  in-
c l u d i n g  a l l  h i g h - r i s k  s u b s e t s  ( 80  years  of  age  or  older,  EF
＜0.25, concurrent chronic obstructive pulmonary disease, pri-
or  renal  failure,  prior  neurologic  event  and  reoperation)  [22].
But  what  about  the  mid-  or  long-term  results  of  the 
off-pump  myocardial  revascularization  in  patients  with  renal 
dysfunction? 
In an analysis of current trends that divided the study peri-
od  into  4  periods  of  time,  Bechtel  et  al.  demonstrated  that 
improvement in perioperative survival after cardiac surgery in 
dialysis  dependent  patients  in  recent  years  does  not  con-
tinuously  improve  the long-term  prognosis [8].  They  also no-
ticed  that  overall  survival  was  significantly  dependent  on  the 
type  of  surgery  and  was  better  for  patients  receiving  isolated 
myocardial  revascularization  than  isolated  valve  surgery  and 
myocardial  revascularization  with  concomitant  valve  surgery. 
Although we didn’t analyze the trend over time in our study, 
5  patients  among  in-hospital  death  of  a  total  of  6  patients  of 
on-pump  group  received  surgery  before  the  year  2004  (5 
deaths out of  a total  of 69  patients  who  were operated  on in 
1999∼2003,  and  1  death  out  of  a  total  of  34  patients  who 
were  operated  on  in  2004∼2009).
Dewey  et  al.  studied  patients  with  end-stage  renal  disease 
undergoing  myocardial  revascularization,  comparing  the  re-
sults  of  on-pump  group  to  off-pump  group  [7].  Although 
there were early mortality benefits, the long-term survival rate 
was  significantly  worse  in  patients  revascularized  using 
off-pump  method  (p=0.03).  The  authors  suggest  the  sig-
nificantly  fewer  number  of  grafts  performed  in  the  off-pump 
group may be related to the cause of lower mid- or long-term 
survival. 
However  in  our  study,  there  is  no  difference  in  the 
mid-term  survival  of  patient  with  renal  insufficiency  between 
the  on-pump  group  and  off-pump  group  (p=0.57).  Particular-
ly,  both  groups  have  a  similar  total  number  of  targets  with 
grafts,  and  distal  number  of  targets  with  arterial  grafts  are 
even  greater  in  the  off-pump  group  (p＜0.001).  In  addition, 
the  revascularized  territories  were  not  different  between  the 
two  groups.  Perhaps  increased  experience  and  new  devices 
for the stabilization of the heart make it possible for surgeons 
to adeptly perform complete myocardial revascularization with 
off-pump  methods.  Because  postoperative  angiography  was 
not  performed  in  all  patients,  we  cannot  guarantee  the  pa-
tency  of  the  bypass  grafts;  however  off-pump  myocardial  re-
vascularization  is  not  a  difficult  surgery  for  multiple  or  com-
plete  revascularization.
Graft  patency  is  no  less  important  than  the  number  of 
grafts. Although not a study dealing exclusively with patients 
with  renal  insufficiency,  Puskas  et  al.  reported  that  graft  pa-
tency  was  not  different  between  the  off-pump  group  and  the 
on-pump group at 1 month postoperative data [23]. However, 
in  another  study  by  Khan  et  al,  the  authors  found  better  pa-
tency  of the  graft  was shown  in the  on-pump  group than the 
off-pump group (98% versus 88% respectively, p=0.002). The 
interesting  finding  of  this  study  is  that  graft  patency  in  both 
groups  show  different  statistical  results  according  to  the  re-
vascularized  territories  and  the  kind  of  grafts  that  was  used 
[24]. In considering the susceptibility to development of athe-
rosclerosis  in  the  coronary  arteries  of  patients  with  renal  in-
sufficiency,  graft  patency  may  be  one  of  the  other  key  in-
dependent  determinants  that  affect  mid-  or  long-term  results 
i n  t h e s e  p a t i e n t s .
This  study  has  several  limitations.  First,  we  didn’t  always 
assess graft patency postoperatively at regular intervals due to 
the  concern  of  renal  toxicity  of  radiologic  contrast,  which Hwan Wook Kim, et al
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could affect the survival rate. Some patients refused to under-
go  follow-up  angiography  because  they  had  no  symptoms. 
Second,  information  on  the  duration  of  preoperative  dialysis 
was not obtained from medical  records.  Generally, the longer 
the history of preoperative hemodialysis, the lower the surviv-
al  rate.  Third,  the  current  study  is  not  a  prospective  random-
ized study, but retrospective observation study. Finally, a rela-
tively  short term follow-up  duration,  a small  sample size  and 
a  selection bias  for  the choice of  utilization of  extracorporeal 
circulation  may  affect  the  results  of  survival  analysis.
CONCLUSION
In  conclusion,  off-pump  myocardial  revascularization  does 
not  affect  the  number  of  bypass  grafts  and  does  not  affect 
mid-term  survival  for  patients  with  renal  insufficiency,  in 
s p i t e  o f  h a v i n g  t h e  b e n e f i t  o f  early  mortality,  compared  to 
on-pump  myocardial  revascularization.  Especially,  for  patients 
who  are  likely  to  take  periodic  renal  replacement  therapy 
postoperatively,  regardless  of t h e  u s e  o f  a r t e r i a l  o r  v e n o u s  
grafts,  myocardial  revascularization  with  a  large  number  of 
total grafts has a beneficial effect of increasing mid-term sur-
vival,  irrespective  of  utilizing  extracorporeal  bypass.
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